The use of nanotechnology in cardiovascular disease

Chandarana, Meera and Curtis, Anthony and Hoskins, Clare (2018) The use of nanotechnology in cardiovascular disease. Applied Nanoscience, 8 (7). 1607–1619. (https://doi.org/10.1007/s13204-018-0856-z)

[thumbnail of Chandarana-etal-AN2018-The-use-nanotechnology-cardiovascular-disease]

Preview

Text. Filename: Chandarana_etal_AN2018_The_use_nanotechnology_cardiovascular_disease.pdf
Final Published Version
License:

Download (1MB)| Preview

Abstract

Cardiovascular diseases claim a number of lives globally; many of which are preventable. With the increase in diets that consist of high saturated fat, salt, and sugar, people often living sedentary lifestyles, and a rise in cases of obesity, the incidence of cardiovascular disease is increasing. These contributing factors, coupled with more advanced methods of diagnosis, have delivered statistics that clearly show that there is a rising trend in the prevalence of cardiovascular disease. Treatment for cardiovascular diseases is limited currently to oral medicines or invasive surgery. There is a huge gap in this area of medicine for novel therapeutics for improved patient outcomes. Nanotechnology may provide a solution to more effective treatment of disease, with better prognoses and a reduced side effect profile. This review will explore for potential solutions to the limited pharmacological therapies currently on the market and the future that lies ahead for the place of nanotechnology within cardiovascular medicine.

ORCID iDs

Chandarana, Meera, Curtis, Anthony and Hoskins, Clare

;

Share and Export

Item metadata

Item type:	Article
ID code:	70511
Dates:	Date Event 16 August 2018 Published 10 August 2018 Accepted
Subjects:	Medicine
Department:	Faculty of Science > Pure and Applied Chemistry
Depositing user:	Pure Administrator
Date deposited:	14 Nov 2019 11:35
Last modified:	15 Nov 2024 01:12
URI:	https://strathprints.strath.ac.uk/id/eprint/70511

CORE (COnnecting REpositories)